Valproate and its major metabolite E-2-en-valproate induce different effects on behaviour and brain monoamine metabolism in rats

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 61-67

  Löscher, Wolfgang ^a   Hönack, Dagmar ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); Anticonvulsant; Dopamine; Epilepsy; GABA ( aminobutyric acid); Noradrenaline

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ANTICONVULSIVE AGENT; DOPAMINE; DRUG METABOLITE; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MONOAMINE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; WET DOG SHAKES;

EID: 17044460311     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00831-4     Document Type: Article

References (30)

1. Baf, M.H.M., M.N. Subhash, K.M. Lakshmana and B.S.S.R. Rao, 1994, Sodium valproate induced alterations in monoamine levels in different regions of the rat brain, Neurochem. Int. 24, 67.
2. Balfour, J.A. and H.M. Bryson, 1994, Valproic acid - a review of its pharmacology and therapeutic potential in indications other than epilepsy, Cns. Drugs 2, 144.
3. Biggs, C.S., B.R. Pearce, L.J. Fowler and P.S. Whitton, 1992, Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study, J. Neurochem. 59, 1702.
4. Bolanos, J.P. and J.M. Medina, 1993, Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta-2-valproate in neonatal rat brain, Mol. Pharmacol. 43, 487.
5. Chapman, A., P.E. Keane, B.S. Meldrum, J. Simiand and J.C. Vernieres, 1982, Mechanism of anticonvulsant action of valproate, Progr. Neurobiol. 19, 315.
6. Cotariu, D., J.L. Zaidman and S. Evans, 1990, Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system, Progr. Neurobiol. 34, 343.
7. Davis, R., D.H. Peters and D. Mctavish, 1994, Valproic acid - a reappraisal of its pharmacological properties and clinical efficacy in epilepsy, Drugs 47, 332.
8. Fahn, S., 1978, Post-anoxic myoclonus improvement with valproic acid, New Engl. J. Med. 319, 313.
9. Fletcher, A. and V. Harding, 1981, An examination of the 'wet dog' shake behaviour in rats produced by acute administration of sodium n-dipropylacetate, J. Pharm. Pharmacol. 33, 811.
10. Handley, S.L. and L. Singh, 1986, Neurotransmitters and shaking behaviour - more than a 'gut-bath' for the brain? Trends Pharmacol. Sci. 7, 324.
11. Horton, R.W., G.M. Anlezark, M.C.B. Sawaya and B.S. Meldrum, 1977, Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate, Eur. J. Pharmacol. 41, 387.
12. Kempf, E., G. Mack, C. Schleef and P. Mandel, 1982, Effect of valproic acid on brain serotonin metabolism in isolated and grouped rats, Pharmacol. Biochem. Behav. 17, 49.
13. Lazarova, M., C. Bendotti and R. Samanin, 1983a, Studies on the role of serotonin in different regions of the rat central nervous system on pentylenetetrazol-induced seizures and the effect of di-n-propylacetate, Naunyn-Schmied. Arch. Pharmacol. 322, 147.
14. Lazarova, M., C. Bendotti and R. Samanin, 1983b, The role of different types of adrenergic receptors in pentylenetetrazol-induced seizures and the effect of di-n-propylacetate in the rat, Psychopharmacology 81, 177.
15. Löscher, W., 1993, Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain, Neurochem. Res. 18, 485.
16. Löscher, W. and D. Hönack, 1992, The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems, Eur. J. Pharmacol. 215, 199.
17. Löscher, W. and D. Schmidt, 1993, New drugs for the treatment of epilepsy, Curr. Opin. Invest. Drugs 2, 1067.
18. Löscher, W., G. Böhme, H. Schäfer and W. Kochen, 1981, Effect of metabolites of valproic acid on the metabolism of GABA in brain and brain nerve endings, Neuropharmacology 20, 1187.
19. Löscher, W., M. Vetter, F. Müller, G. Böhme and G. Stoltenburg-Didinger, 1984, Development of a synaptosomal model to determine drug-induced in vivo changes in GABA-levels of nerve endings in 11 brain regions of the rat, Neurochem. Int. 6, 441.
20. Löscher, W., J.E. Fisher, H. Nau and D. Hönack, 1988, Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid, Eur. J. Pharmacol. 150, 221.
21. Löscher, W., R. Annies and D. Hönack, 1991a, The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats, Neurosci. Lett. 128, 191.
22. Löscher, W., D. Hönack, B. Nolting and C.P. Faßbender, 1991b, trans-2-En-valproate: reevaluation of its anticonvulsant efficacy in standardized seizure models in mice, rats and dogs, Epilepsy Res. 9, 195.
23. MacMillan, V., 1979, The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism, Can. J. Physiol. Pharmacol. 57, 843.
24. Nau, H. and W. Löscher, 1984, Valproic acid and metabolites: pharmacological and toxicological studies, Epilepsia 25(1), 14.
25. 2-adrenoceptors, Eur. J. Pharmacol. 152, 197.
26. 2-adrenoceptor stimulation, Psychopharmacology 81, 267.
27. Wester, P., J. Gottfries and B. Winblad, 1987, Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations, J. Chromatogr. 415, 275.
28. Whitton, P.S. and L.J. Fowler, 1991, The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo, Eur. J. Pharmacol. 200, 167.
29. Whitton, P.S., D. Oreskovic, Z. Marcovic, D. Skarpa and M. Bulat, 1983, Effect of the antiepileptic di-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid, Eur. J. Pharmacol. 91, 57.
30. Whitton, P.S., D. Oreskovic, B. Jernej and M. Bulat, 1985, Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain, J. Pharm. Pharmacol. 37, 199.